1,009 results on '"Gatter, K"'
Search Results
202. Dendritic reticulum cells in reactive lymph nodes and tonsils: an immunohistological study.
203. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.
204. T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic, and immunohistochemical analysis of five cases.
205. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.
206. A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues.
207. Schistosomiasis-associated Squamous Lesions of the Bladder. Expression of Low Molecular Weight Cytokeratin Proteins.
208. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.
209. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
210. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
211. Langerhans'cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia.
212. Langerhans'cells in human cervical epithelium: an immunohistological study.
213. The Value of Immunocytochemistry in Differentiating High-Grade: Lymphoma from Other Anaplastic Tumours: A study of anaplastic tumours from 1940 to 1960.
214. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen.
215. Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen.
216. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections.
217. EBM/11 reactivity in malignant histiocytosis.
218. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract.
219. Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.
220. Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages.
221. Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens.
222. Giant cell myocarditis associated with lymphoma: an immunocytochemical study.
223. The role of immunocytochemistry in diagnostic pathology.
224. Practical value of genotypic analysis for diagnosing lymphoproliferative disorders.
225. Expression of intermediate filament proteins in normal and diseased thyroid glands.
226. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
227. Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.
228. Human lung tumours may coexpress different classes of intermediate filaments.
229. New approach to assessing lung tumours in man.
230. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
231. Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells.
232. Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study.
233. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
234. Role of immunohistochemistry in diagnosis of nasopharyngeal tumours.
235. Giant cell myocarditis: evidence for the macrophage origin of the giant cells.
236. Transferrin receptors in human tissues: their distribution and possible clinical relevance.
237. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
238. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast.
239. Distinct Angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.
240. p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON-HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS.
241. Diagnostic immunocytochemistry: Achievements and challenges.
242. The utility of Ki67 immunostaining, nuclear organizer region counting, and morphology in the assessment of follicular lymphomas.
243. Osteoclasts contain macrophage and megakaryocyte antigens.
244. An immunohistological study of giant-cell tumour of bone: Evidence for an osteoclast origin of the giant cells.
245. Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.
246. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
247. Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.
248. Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.
249. Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.
250. Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.